MedTrace Logo

Cell Cycle Arrest Proteins for Early Diagnosis of Acute Kidney Injury After Solid Organ Transplant

NCT05907434 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2025-03-07

No results posted yet for this study

Summary

Renal failure is a common complication of lung transplant (LUTX) and orthotopic liver transplantation (OLTX). Early diagnosis of acute kidney injury (AKI) in this cohort is of utmost importance, since AKI after solid organ transplant is associated with worsened short and long-term outcomes. To now, early biomarkers of renal failure based on the measurement of cell-cycle arrest proteins have never been tested in this population.

Conditions

Interventions

DIAGNOSTIC_TEST

Nephrocheck (AKI score)

Early biomarker of AKI

Sponsors & Collaborators

  • Policlinico Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2024-12-31
Completion
2025-03-01

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05907434 on ClinicalTrials.gov